Pilot Study of Smart Inhaler Use for Asthma Management in Adolescents With Intellectual and Developmental Disabilities Ages 10 to 17

What this Trial Is About

Researchers are investigating whether using a smart inhaler daily can help adolescents aged 10 to 17 years who have intellectual and developmental disabilities IDD and moderate-to-severe asthma. The study aims to see if the smart inhaler is practical and acceptable for this group, whether it improves correct medication use, and if it leads to better lung function. This is a pilot randomized controlled trial conducted at a large childrens hospital with 30 participants. Participants are randomly assigned to one of two groups one group uses the smart inhaler daily for 8 weeks, while the other group receives standard asthma education. All participants attend three study visits spaced four weeks apart during the 8-week period. The study measures include the feasibility, acceptability, and usability of the smart inhaler, as well as asthma inhaler proficiency and lung function tests. During the study, researchers collect data on how completely participants use the device and their satisfaction through surveys. They assess inhaler technique both by the smart inhaler and by a trained observer. Lung function is evaluated using spirometry, measuring forced expiratory volume in one second FEV1 and peak expiratory flow PEF. Data are analyzed using statistical models to understand the impact of the smart inhaler on asthma management. The total participation lasts 8 weeks with assessments at baseline, 4 weeks, and 8 weeks.

Using a Smart Inhaler to Support Asthma Management in Adolescents With Intellectual and Developmental Disabilities